BRD7 anticorps (C-Term)
Aperçu rapide pour BRD7 anticorps (C-Term) (ABIN927760)
Antigène
Voir toutes BRD7 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Purification
- Purified
-
Immunogène
- BRD7 antibody was raised in rabbit using the C terminal of BRD7 as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
BRD7 Blocking Peptide, (ABIN939729), is also available for use as a blocking control in assays to test for specificity of this BRD7 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- BRD7 (Bromodomain Containing 7 (BRD7))
-
Autre désignation
- BRD7
-
Sujet
- BRD7 is an activator of the Wnt signaling pathway in a DVL1-dependent manner by negatively regulating the GSK3B phosphotransferase activity. It induces dephosphorylation of GSK3B at 'Tyr-216'. Synonyms: Polyclonal BRD7 antibody, Anti-BRD7 antibody, bromodomain containing 7 antibody, BP75 antibody, CELTIX1 antibody, NAG4 antibody.
Antigène
-